Teva Pharmaceuticals USA Inc. is recalling three lots of Neomycin Sulfate (neomycin sulfate) Tablets, USP 500 mg, sold in 100-count bottles. The recall was initiated because teflon, a foreign material, was discovered in the active pharmaceutical ingredient used to make the tablets. Neomycin Sulfate is a prescription antibiotic used to reduce bacteria in the intestines. No incidents or injuries have been reported in connection with this issue.
The presence of teflon in the medication poses a potential health risk to patients who ingest the tablets. Consumers should contact their doctor or pharmacist if they have experienced any health problems that may be related to taking this medication.
You have 2 options:
Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.